Muzaffar Qazilbash, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the findings of a study investigating the impact of gender on survival outcomes in patients with multiple myeloma undergoing autologous transplantation. Overall, the study reported that there was no significant difference in progression-free survival (PFS) between males and females. However, a subset analysis found that females younger than 50 years old appeared to have a shorter PFS when compared to age-matched males. This result could be hypothesis-generating if reproduced in other datasets. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.